L’OCDE poursuit des travaux sur les données et les indicateurs de santé en vue d’améliorer les comparaisons à l’échelle internationale et les analyses économiques des systèmes de santé.
Cette nouvelle édition du Panorama de la santé présente les données comparables les plus récentes sur les principaux indicateurs de la santé et des systèmes de santé des pays membres de l’OCDE. Pour un sous-groupe d’indicateurs, elle contient aussi des données se rapportant à des pays partenaires dont l'Afrique du Sud, le Brésil, la Chine, la Colombie, le Costa Rica, la Fédération de Russie, l'Inde, l'Indonésie, la Lettonie et la Lituanie. Cette édition contient deux nouveautés : une série de tableaux de bord qui résument la performance des pays de l’OCDE sur des indicateurs clés de santé et des systèmes de santé, et un chapitre spécial sur les tendances récentes des dépenses pharmaceutiques parmi les pays de l’OCDE. Cette édition contient également de nouveaux indicateurs sur la migration du personnel de santé et sur la qualité des soins de santé.
De trop nombreuses vies sont encore perdues parce que la qualité des services de santé s’améliore trop lentement pour faire face au vieillissement des populations et au nombre croissant de personnes souffrant d’une ou de plusieurs maladies chroniques, selon un nouveau rapport de l'OCDE.
Français, PDF, 1,736kb
Principaux résultats sur le système de santé français
The book presents a background study of DRG-based payment systems, drawing on the experience of implementing such hospital funding arrangements internationally, including an overview of developments in the Asia and Pacific region. It underscores the need for countries to be clear about their purpose and objective for introducing Diagnosis Related Groups, as well as their place in health-care financing reform, and for policy-makers to reflect on the importance of country-specific starting points, objectives and context in which the hospital payment reforms are being implemented. Chapter 4 – written by Yuki Murakami and Luca Lorenzoni – investigates the evidence regarding the impact on cost, quality and efficiency of the introduction of a DRG-based payment system.
Antimicrobial therapies have played an essential role in the treatment of infections in humans and animals and have significantly improved population health. All these applications are now endangered by the increasing spread of microbes that are resistant to antimicrobial medications. The OECD will present during the G7 Health Ministers Meeting in Berlin on October 8 some key findings and policy recommendations on how to deal with AMR.
All countries are investing in health data. There are however significant cross-country differences in data availability and use. Some countries stand out for their innovative practices enabling privacy-protective data use while others are falling behind with insufficient data and restrictions that limit access to and use of data, even by government itself. Countries that develop a data governance framework that enables privacy-protective data use will not only have the information needed to promote quality, efficiency and performance in their health systems, they will become a more attractive centre for medical research. After examining the current situation in OECD countries, a multi-disciplinary advisory panel of experts identified eight key data governance mechanisms to maximise benefits to patients and to societies from the collection, linkage and analysis of health data and to, at the same time, minimise risks to the privacy of patients and to the security of health data. These mechanisms include coordinated development of high-value, privacy-protective health information systems, legislation that permits privacy-protective data use, open and transparent public communication, accreditation or certification of health data processors, transparent and fair project approval processes, data de-identification and data security practices that meet legal requirements and public expectations without compromising data utility and a process to continually assess and renew the data governance framework as new data and new risks emerge.
Many European countries saw further reductions in health spending in 2013, according to OECD Health Statistics 2015. Health spending continued to shrink in Greece, Italy and Portugal in 2013. Most countries in the European Union reported real per capita health spending below the levels of 2009. Outside of Europe, health spending has been growing at around 2.5% per year since 2010.
The health systems we enjoy today, and expected medical advances in the future, will be difficult to finance from public resources without major reforms. Public health spending in OECD countries has grown rapidly over most of the last half century. These spending increases have contributed to important progress in population health: for example, life expectancy at birth has increased, rising on average by ten years since 1970. The challenge now is to sustain and enhance these achievements in a context of tight fiscal constraints in many countries combined with upward pressure on health spending from factors such as new technological advances and demographic changes. Finding policies that can make health spending more sustainable without compromising important achievements in access and quality requires effective co-operation between health and finance ministries. Sound governance and co-ordination mechanisms are therefore essential to ensure effective policy choices. Prepared by both public finance and health experts, this report provides a unique detailed overview of institutional frameworks for financing health care in OECD countries. One of the main features of this book is a comprehensive mapping of budgeting practices and governance structure in health across OECD countries.
The OECD/Korea Policy Centre fosters the exchange of technical information and policy experiences relating to the Asia Pacific region in areas such as health statistics, pension reforms and social policy and expenditure.